2,6-Bis[(4R,5R)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl]pyridine, 97%,99% ee, 250mg

Nazartinib, 250mg

3-cyclopropylprop-2-ynoic acid, 95.0%, 1g

5-Bromo-2-chloronicotinonitrile, 97.0%, 100g

2,6-Difluorobenzyl bromide, 97.0%, 100g

Ethyl 2-amino-6-fluoro-3-methylbenzoate, 98%, 500mg

Methyl (1R,3R)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylate, 97%, 500mg

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(prop-2-yn-1-yl)pentanamide, 95+%, 5g

Ethyl 1-Cyanocyclopentanecarboxylate, 95.0%, 1g

p-Nitrophenyl Octadecyl Ether, 98%, 10g

Pentasodium Diethylenetriaminepentaacetate (ca. 40% in Water, ca. 1.0mol/L)500g

[(2-isopropoxypyridin-3-yl)methyl]amine, 95.0%, 1g

Zinc bromide, anhydrous 98+% 250 g